Literature DB >> 12675109

Prospective evaluation of a modified Fennerty regimen for anticoagulating elderly people.

M W Cooper, T J Hendra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 12675109     DOI： 10.1093/ageing/27.5.655

Source DB:  PubMed          Journal:  Age Ageing        ISSN： 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  4 in total

Review 1.  The future prospects of pharmacogenetics in oral anticoagulation therapy.

Authors:  Farhad Kamali; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

2.  Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.

Authors:  Benjamin D Horne; Petra A Lenzini; Mia Wadelius; Andrea L Jorgensen; Stephen E Kimmel; Paul M Ridker; Niclas Eriksson; Jeffrey L Anderson; Munir Pirmohamed; Nita A Limdi; Robert C Pendleton; Gwendolyn A McMillin; James K Burmester; Daniel Kurnik; C Michael Stein; Michael D Caldwell; Charles S Eby; Anders Rane; Jonatan D Lindh; Jae-Gook Shin; Ho-Sook Kim; Pantep Angchaisuksiri; Robert J Glynn; Kathryn E Kronquist; John F Carlquist; Gloria R Grice; Robert L Barrack; Juan Li; Brian F Gage
Journal:  Thromb Haemost       Date:  2011-12-21       Impact factor: 5.249

Review 3.  Optimal loading dose for the initiation of warfarin: a systematic review.

Authors:  Carl Heneghan; Sally Tyndel; Clare Bankhead; Yi Wan; David Keeling; Rafael Perera; Alison Ward
Journal:  BMC Cardiovasc Disord       Date:  2010-04-19       Impact factor: 2.298

Review 4.  Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.

Authors:  Eric Pautas; Isabelle Gouin-Thibault; Matthieu Debray; Pascale Gaussem; Virginie Siguret
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.